Abstract Bone mineralization is a carefully orchestrated process, regulated by a number of promoters and inhibitors that function to ensure effective hydroxyapatite formation. Here we sought to identify new regulators of this process through a time series microarray analysis of mineralising primary osteoblast cultures over a 27 day culture period. To our knowledge this is the first microarray study investigating murine calvarial osteoblasts cultured under conditions that permit both physiological extracellular matrix mineralization through the formation of discrete nodules and the terminal differentiation of osteoblasts into osteocytes. RT-qPCR was used to validate and expand the microarray findings. We demonstrate the significant upregulation of [6,000 genes during the osteoblast mineralization process, the highest-ranked differentially expressed genes of which were those dominated by members of the PPAR-c signalling pathway, namely Adipoq, Cd36 and Fabp4. Furthermore, we show that the inhibition of this signalling pathway promotes matrix mineralisation in these primary osteoblast cultures. We also identify Cilp, Phex, Trb3, Sox11, and Psat1 as novel regulators of matrix mineralization. Further studies examining the precise function of the identified genes and their interactions will advance our understanding of the mechanisms underpinning biomineralization.
Introduction
During endochondral bone formation, chondrocytes and osteoblasts mineralize their extracellular matrix (ECM) by promoting the initial formation of crystalline hydroxyapatite (HA) in the sheltered interior of membrane-limited matrix vesicles (MVs). This is followed by the modulation of matrix composition to further promote propagation of HA outside of the MVs [1] . This biphasic mineralization process is critically dependent on a regulated balance of a number of factors which include calcium and inorganic phosphate (P i ), ECM proteins, and the presence of mineralization inhibitors such as inorganic pyrophosphate (PP i ), matrix gla protein, and osteopontin [2, 3] . Three osteoblast molecules have been identified as affecting the controlled deposition of HA by regulating the extracellular levels of PP i , and in turn, of osteopontin: tissue-nonspecific alkaline phosphatase (ALP), ecto-nucleotide pyrophosphatase/ phosphodiesterases-1 (NPP1) and the ankylosis protein (ANK) [2, 4, 5] .
ALP is responsible for the generation of P i from its substrate PP i for HA crystallisation and the restriction of PP i , to maintain a P i /PP i ratio permissive for normal bone mineralization [1, 5, 6] . NPP1 inhibits HA precipitation by its PP i -generating properties within the ECM whereas ANK functions as a transmembrane PP i -channelling protein, allowing PP i molecules to pass through the plasma membrane from the cytoplasm to ECM [7, 8] . The bone specific phosphatase PHOSPHO1 is also essential for the accumulation of P i within MVs and bone mineralization [9] [10] [11] [12] . Indeed, we have found that PHOSPHO1 and ALP have non-redundant functions in regulating HA formation and mineralization; genetic ablation of either produces a hypomineralized, functionally-impaired skeleton and spontaneous fracture, whilst simultaneous ablation produces a complete lack of all skeletal mineralization [12, 13] .
Further mechanisms unrelated to the supply and hydrolysis of PP i also exist to control matrix mineralization. Extracellular nucleotides adenosine triphosphate (ATP), and uridine triphosphate (UTP) signal via the P2Y 2 receptor to inhibit bone mineralization, and the ATP-sensitive P2X 1 and P2X 7 receptors also negatively regulate bone mineralization [14] . Recent progress has also identified roles for key non-collagenous proteins in the regulation of HA crystal initiation and propagation, including bone sialoprotein (BSP), dentin sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP1) and matrix extracellular phosphoglycoprotein (MEPE) [15] . Furthermore, the formation of multicellular networks permeating the mineralized ECM by osteocytes may play pivotal mechano-modulatory roles in directing bone formation and mineralization [16] .
Despite these recent advances in our knowledge, the full mechanisms underpinning osteoblast matrix mineralization have yet to be fully elucidated. In the present study we have exploited a microarray approach to identify novel genes that are differentially expressed during the mineralization process. This data presented in this study is novel as it is the first microarray study, to our knowledge, which investigates murine calvarial osteoblasts cultured under conditions which use low concentrations of b-glycerophosphate (bGP), a commonly used exogenous organic phosphate source has previously been shown to cause dystrophic mineralisation when used in excessive concentrations [14] . Therefore, here the conditions in which the primary osteoblasts were cultured permit physiological ECM mineralization through the formation of discrete nodules and the terminal differentiation of osteoblasts into osteocytes. The identification of novel differentially expressed genes during the process of bone mineralization may open up new potential avenues for the therapeutic treatment of clinical mineralization disorders including osteoporosis, osteopetrosis and vascular calcification.
Materials and methods

Ethics statement
All animal experiments were approved by The Roslin Institute's Animal Users Committee and the animals were maintained in accordance with Home Office (UK) guidelines for the care and use of laboratory animals.
Primary osteoblast isolation
Primary mouse calvarial osteoblasts were obtained from 3-day-old C57Bl/6 mice by sequential enzyme digestion of excised calvarial bones using a four-step process as has previously been described [17] [1 mg/ml collagenase type II in Hanks' balanced salt solution (HBSS) for 10 min; 1 mg/ml collagenase type II in HBSS for 30 min; 4 mM ethylenediaminetetraacetic acid (EDTA) for 10 min; 1 mg/ml collagenase type II in HBSS for 30 min]. The first digest was discarded and the cells subsequently obtained were re-suspended in growth medium consisting of a-MEM (Invitrogen, Paisley, UK) supplemented with 10 % FCS (Invitrogen) and 1 % gentamycin (Invitrogen). Cells were cultured for 4 days in a humidified atmosphere (95 % air/5 % CO 2 , 37°C) in T75 tissue culture flasks (Greiner Bio-One, GmbH, Frickenhausen, Baden-Württemberg, Germany) until confluent.
Primary osteoblast culture
Osteoblasts were seeded at a density of 1.5 9 10 4 cells/ cm 2 in growth medium. At confluency (day 0), growth medium was supplemented with 2.5 mM bGP and 50 lg/ ml ascorbic acid for up to 28 days to induce matrix calcification. Incubation was at 37°C in a humidified atmosphere of 95 % air/5 % CO 2 and the medium was changed every second/third day. Previous studies have shown that during this 28 day culture period, murine calvarial osteoblast cultures display increasing ECM mineralization associated with elevated TNAP activity and the up-regulation of osteocyte markers, DMP1, E11 and sclerostin [18, 19] . This in vitro model mimics the full osteoblast differentiation cascade observed in vivo and is, therefore, appropriate for the identification of potential novel regulators of matrix mineralization. Primary osteoblasts were cultured in the presence of varying concentrations (0-10 lM) of the PPAR-c antagonist T0070907 (SigmaAldrich, Dorset, UK) for 18 days.
ATDC5 cells
Chondrogenic ATDC5 cells (RIKEN cell bank, Ibaraki, Japan) were cultured as described previously [20] in differentiation medium [DMEM/F-12 (1:1) with GlutaMAX I containing 5 % FBS, 1 % insulin transferrin and selenium, 1 % sodium pyruvate and 0.5 % gentamicin (Invitrogen)] at a density of 6000 cells/cm 2 . 10 mM bGP and 50 lg/ml ascorbic acid were added once the cells had reached confluency. Cells were incubated in a humidified atmosphere (37°C, 5 % CO 2 ) for up to 18 days. 
Microarray data analysis
Normalisation across all arrays was achieved using the robust multi-array average (RMA) expression measure which results in expression measures (summarised intensities) in log base 2 [21] . Comparisons were undertaken using linear modelling. Subsequently, empirical Bayesian analysis was applied (including vertical (within a given comparison) P value adjustment for multiple testing, which controls for false discovery rate) for which the Bioconductor package limma was used [22] . An overview of the underlying biological changes occurring within each comparison can be obtained by functional enrichment analysis. This was performed from two perspectives, namely KEGG pathway membership and Gene Ontology (GO) terms. The level of statistical significance for functional analysis was chosen to be the most stringent level at which 1 % of the array features were, on average, significant. For the current dataset, adjusted P \ 0.0001 was appropriate for the comparisons performed. Significant genes (adjusted P \ 0.0001) from each comparison were analysed for enrichment of KEGG pathways and GO terms using separate hypergeometric tests. Enrichment (P \ 0.001) was assessed for up-regulated and down-regulated pathways and genes separately.
Detection of mineralization
Calcium deposition was evaluated by alizarin red staining [18, 20, 23] . Cells were washed with phosphate buffered saline (PBS), fixed in 4 % paraformaldehyde for 5 min at 4°C, stained with 2 % alizarin red (pH 4.2) for 10 min at room temperature and rinsed with distilled water. Calcium deposition was also assessed by HCl leaching. Cells were decalcified in 0.6 N HCl overnight and free calcium determined colorimetrically by a stable interaction with phenolsulphonephthalein using a commercially available kit (Randox Laboratories Ltd., County Antrim, UK) and corrected for total protein concentration, following extraction using 1 mM NaOH in 0.1 % SDS (Bio-Rad Laboratories Ltd., Hemel Hempstead, UK).
Analysis of gene expression using quantitative RT-PCR
Quantitative PCR (qRT-PCR) was used to confirm changes in the expression of selected genes. RNA was extracted at days 0, 7, 14, 21 and 28 of culture using the RNeasy mini kit (Qiagen) according to the manufacturer's instructions. For each sample, total RNA content was assessed by absorbance at 260 nm and purity by A260/A280 ratios. RNA was reverse transcribed and the PCR reaction undertaken as described previously [18, 23] . All genes were analysed with the SYBR green detection method using the Stratagene Mx3000P real-time qPCR system (Stratagene, CA, USA). Each PCR was run in triplicate. All gene expression data were normalised against Gapdh and the control values expressed as 1 to indicate a precise fold change value for each gene of interest. All primers were purchased from Qiagen (sequences unknown), with the exception of Gapdh (sequence unknown) and Phex (forward: CTAACCACCCACTCCCACTT, reverse: CCAA TAGACTCCAAACCTGAAGA) which were purchased from Primer Design (Southampton, UK).
Results
Calvarial osteoblasts at confluency had negligible amounts of alizarin red staining (calcium deposition) (Fig. 1a) . Further culture in mineralising conditions for an additional 7, 14, 21 and 28 days resulted in the formation of discrete nodules, as detected by increased alizarin red staining (Fig. 1a) . In addition, significant increases in mRNA expression of key genes associated with osteoblast mineralization, tissue non-specific alkaline phosphatase (Alpl) (14.4-fold change; P \ 0.001) and osteocalcin (Ocn) (40.4-fold change; P \ 0.001), were observed at day 7, with increased expression maintained throughout the culture period (Fig. 1b, c, respectively) . These data confirm the formation of calcified matrix in calvarial osteoblasts over the 28-day time course examined.
In order to identify novel mediators of bone mineralization, microarray analysis was undertaken during the initiation and progression of the in vitro osteoblast mineralization time course. Total RNA that was therefore isolated from primary osteoblasts at 0, 9 and 27 days of culture was hybridised to a Affymetrix Murine 430 2.0 Array. Analysis in Bioconductor limma software demonstrated that following normalisation, 6,710 genes were upregulated and 3541 genes down-regulated following 9 days of culture (n = 4, [1.5-fold change). There were 6,964 genes up-regulated and 4,673 down-regulated at day 27 of culture, in comparison to day 0 (n = 4, [1.5-fold change). The top twenty up-regulated and down-regulated genes at day 9 and day 27 are listed in Tables 1 and 2, respectively. Transcripts significantly up-regulated during mineralization at both day 9 and day 27 compared to day 0 included key members of the peroxisome proliferator-activated receptor gamma (PPAR-c) signalling pathway, namely adiponectin (Adipoq), cluster of differentiation 36 (Cd36), and fatty acid binding protein 4 (Fabp4). PPAR-c too was significantly up-regulated in these mineralizing cultures. Cartilage intermediate layer protein (Cilp) and phosphateregulating neutral endopeptidase (Phex) were also markedly up-regulated (Table 1) . Conversely, transcripts significantly down-regulated included Tribbles 3 (Trib3), phosphoserine aminotransferase 1 (Psat1) and sex determining region Y-box (Sox11) ( Table 2) . Functional enrichment analysis identified the significant up-regulation of the PPAR-c signalling pathway (Fig. 2) .
To validate the microarray expression data, the eight mineralization-responsive genes listed above were selected for analysis of gene expression by qRT-PCR in the calvarial osteoblasts cultured for 28 days under mineralizing conditions. Analysis at day 7 revealed significant increases in the mRNA expression of Adipoq (1460-fold change; P \ 0.001, Fig. 3a) , Cd36 (350-fold change; P \ 0.001, Fig. 3b ), Fabp4 (270-fold change; P \ 0.001, Fig. 3c ), Cilp (45-fold change; P \ 0.001, Fig. 3d ) and Phex (190-fold change; P \ 0.001, Fig. 3e ). Increased expression of these genes was maintained throughout the culture period (Fig. 3a-e) . The induction of these genes therefore paralleled the expression patterns obtained by microarray analysis. Similarly, a significant down-regulation of Trib3 (0.6-fold change; P \ 0.001, Fig. 4a ), PsatI (0.25-fold change; P \ 0.001, Fig. 4b ) and Sox11 (0.6-fold change; P \ 0.001, Fig. 4c ) was detected by qRT-PCR analysis at day 7. Reduced expression of these genes was also observed throughout the culture period (Fig. 4a-c) .
To confirm a role for the PPAR-c signalling pathway, we examined the effects of PPAR-c inhibition on calvarial osteoblast matrix mineralisation. Addition of the PPAR-c antagonist T0070907 to osteoblast cultures showed a dosedependent promotion of matrix mineralisation (P \ 0.05 upon addition of 10 lM in comparison to 0 lM, Fig. 5a ), highlighting the critical role for this pathway in the osteoblast maturation processes. We also sought to examine whether the key components of this pathway identified here are involved in bone formation through endochondral ossification. For this we utilised the ATDC5 cell line which we have previously shown to be an excellent model of this fundamental process [20] . Consistent with our results in primary osteoblast cultures, we observe increases in
Adipoq and Cd36 mRNA expression and significant decreases in Psat1 expression over the culture period (compared to day 2, P \ 0.05, Fig. 5b-d) . Together our data have identified and confirmed eight genes differentially expressed during the process of calvarial osteoblast mineralization under conditions that permit both physiological ECM mineralization and terminal differentiation into osteocytes.
Discussion
Despite recent advances in our knowledge, the full mechanisms underpinning osteoblast matrix mineralization have yet to be fully elucidated. This study has clearly demonstrated differential expression of novel genes in murine primary calvarial osteoblast cultures, cultured in the presence of low bGP concentrations, permitting physiological mineralisation. Furthermore, many of these genes have not been reported in previous osteoblast mineralization microarray studies [24] . These marked differences are likely to be directly attributable to the culture conditions in the present study that enabled the physiological mineralization of the ECM and the terminal differentiation of osteoblasts into osteocytes in vitro.
Microarray analysis, functional enrichment and qRT-PCR validation studies together identified the up-regulation of Adipoq, Cd36 and Fabp4 during in vitro osteoblast mineralization, key genes involved in the PPAR-c signalling pathway and adipogenesis. Furthermore, here we show the addition of the PPAR-c antagonist, T0070907, promotes osteoblast matrix mineralisation. This highlights the critical role of this pathway in this process, and is in concordance with a previous study in which tumor necrosis factor-alpha (TNF-alpha) is implicated as the upstream regulator of this [25] . It may seem somewhat paradoxical that this pathway which seemingly acts to inhibit osteoblast matrix mineralisation is significantly upregulated in our microarray analysis, however, as this is becoming more frequently observed and accepted, in biology, feedback systems exist to avoid the pathological state. Thus the upregulation of the PPAR-c signalling pathway here may be acting to prevent excessive and/or ectopic matrix mineralisation. This notion is supported by the critical role for this pathway in endochondral ossification shown here, and in the literature with the PPAR-c knockout mouse displaying a distinct endochondral phenotype characterised by shortened bones, disorganised growth plates, and aberrant expression of markers of endochondral ossification [26] . Furthermore, the distinct expression and roles for the individual genes identified in this study in endochondral ossification have previously been defined [27] [28] [29] [30] . Taken together, this suggests that the PPAR-c signalling pathway and its constituents are key regulators of biomineralization.
Cd36, also known as fatty acid translocase (FAT), is a long chain fatty acid transporter which is present at the plasma membrane and activates the PPARs [31] . Fabp4 and Adipoq act downstream of PPAR-c, and have both previously been shown to be involved in adipocyte differentiation (Fig. 2) . Fabp4 is a member of the FABP family of which nine isoforms have been identified and which have been localised to mature adipocytes and adipose tissue [32] . Similarly, Adipoq is strongly expressed by adipocytes and is known to stimulate the differentiation of osteoblasts through the induction of prostaglandin-endoperoxide synthase 2 and bone morphogenetic protein 2 (BMP2) in mesenchymal cells [33] . Previous microarray analysis of mesenchymal lineage markers in mouse calvaria cell cultures have indicated that adipocyte-associated genes are transcriptionally induced together with osteoblast-associate genes during osteoblast development [34] . Similarly, data has shown that adipocytes emerge along with osteogenic potential in a fraction of fetal rat calvaria cells treated with BRL-49653, a synthetic ligand for PPAR-c [35] . The demonstration that a subset of osteoblasts maintains capacity for adipogenic fate selection, even at relatively mature developmental stages implies an unexpected plasticity with important implications in normal and pathological bone development [36] . The molecular basis by which this subset of osteogenic cells acquires high endogenous expression of adipogenic transcription factors, and the functional significance of this acquisition, remains to be determined. This study has also identified the up-regulation of Phex during in vitro osteoblast mineralization. It has been proposed that a mutation in the human PHEX gene is directly responsible for the phenotypic changes in patients with X-linked hypophosphatemia [37] . Investigation of murine tissues and cell cultures has revealed that Phex is predominantly expressed in osteoblasts and osteocytes in bone, as well as in teeth [38] [39] [40] . PHEX has not been reported to have any direct effects on mineralization, however it is able to rescue the inhibitory effects of the MEPE-ASARM peptide by preventing its release and by proteolytically cleaving the ASARM peptide deeming it inactive [15] . Furthermore, it is well established that the increased expression of ASARM peptides are responsible for the mineralization defect observed in the Hyp mouse model, a model for XLH caused by an inactivating mutation in Phex [41] . The increased expression of Phex observed here is, therefore, indicative of the emerging evidence for a critical role of the ASARM peptides in matrix mineralization.
Our data also demonstrate an increased expression of Cilp during osteoblast mineralization. CILP is a key ECM Fig. 4 Fold changes in mRNA expression of a Trib3 b Psat1 c Sox11 in murine calvarial osteoblasts cultured for 28 days. Results are expressed as mean ± SEM. *P \ 0.05, **P \ 0.01, ***P \ 0.001 compared with day 0 component, expressed predominantly in the articular cartilage [42] . Studies in chondrocytes have demonstrated that both transforming growth factor beta (TGFb) and insulinlike growth factor 1 (IGF1) induce Cilp expression [43] . Whilst Cilp has been implicated in numerous diseases of cartilage, to our knowledge this the first report of CILP expression within osteoblasts. This data, together with previous studies showing that CILP may generate extracellular PP i , highlight the requirement for further investigations into the role of CILP in controlling bone mineralization, potentially through modulation of P i /PP i balance [43] .
The results presented here have also identified the downregulation of Sox11 during osteoblast differentiation and matrix mineralization. Sox11 is a transcription factor which is expressed during embryonic development and tissue remodelling [44] . Whilst this is the first report of altered Sox11 expression in osteoblasts, previous microarray studies have shown that Sox11 is differentially expressed during the initiation of chondrogenesis [45] . Additionally, Sox11 null mice display craniofacial and skeletal malformations, and delayed endochondral ossification [46] . Further studies are therefore required to elucidate the mechanisms through which Sox11 modulates chondrocyte and osteoblast dynamics.
The Psat1 gene codes for a phosphoserine aminotransferase which is involved in cell proliferation in vitro [47] . To our knowledge, this is the first demonstration of reduced expression of Psat1 during osteoblast ECM mineralization. However, a recent study analysing the genes involved in mineralization during differentiation of human periodontal ligament stem cells, also noted a significant down-regulation of Psat1 expression [48] . Together these data suggest a key role for Psat1 in regulating biomineralization across a range of tissue types.
The present study also provides evidence for the downregulation of Trib3. In fact this was the most highly ranked down-regulated gene following both 9 and 27 days of culture. This homolog of the Tribbles family plays a key role in the regulation of the nuclear factor of activated B cells (NF-kappaB) activation, which is known to inhibit osteoblastic bone formation [49] . Furthermore, TRIB3 stabilises the expression of SMAD, the major BMP signalling transcription factor, through its dissociation from the BMPII receptor and its promotion of the subsequent degradation of SMAD ubiquitin regulatory factor 1. Therefore, through this mechanism, TRIB3 has the ability to promote osteogenic differentiation and mineralization [50] . In addition, the BMP signalling pathway has been shown in numerous studies to interact with the Wnt signalling pathway to potentiate its effects on osteoblast differentiation [51] . Sclerostin, a marker of mature deeply embedded osteocytes exerts negative effects of on osteoblastogenesis and bone formation through activation of the Wnt signalling pathway and BMP antagonism [52] . It is therefore plausible that the decreased expression of Trib3 observed in the present study reflects the terminal differentiation of the osteoblast into the osteocyte.
In conclusion, this study exemplifies that the use of array technologies represents a powerful method for the discovery of genes involved in bone mineralization. These results will enable future investigations into the precise mechanisms underpinning osteogenic differentiation. Furthermore, our data will inform future investigations into the molecular mechanisms surrounding diseases of biomineralization such as osteomalacia, vascular calcification and osteoporosis.
